VYCOR MEDICAL INC (VYCO) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US92921M2035

Price
0.04 USD
Market cap
1.47 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

VYCOR MEDICAL INC financials

Fiscal year2025
Revenue1.86 m USD
Gross profit1.56 m USD
Operating income33,900.00 USD
EBIT-72,426.00 USD
Net income-72,426.00 USD
Diluted EPS – continuing operations-0.01 USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About VYCOR MEDICAL INC

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.